Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions. #TCT2-0

Feature | Cath Lab

Shockwave Technology to Sonically Bust Calcified Coronary Lesions Shows Safety and Efficacy in U.S. Pivotal IDE Trial

October 15, 2020 — Shockwave Medical's Intravascular Lithotripsy (IVL) system to treat severely calcified coronary ...

October 16, 2020

Videos | Cath Lab

VIDEO: Demonstration of Intravascular Lithotripsy Breaking Up Calcium

This is an example pf the Shockwave Medical Intravascular Lithotripsy (IVL) catheter system designed to break up heavily ...

October 16, 2020

Positive clinical data from first-in-human studies of the Conformal Medical left atrial appendage closure (LAAC) CLAAS device performed in the U.S. and Prague were presented at 2020 Transcatheter Cardiovascular Therapeutics (TCT) Connect virtual meeting. Two two abstracts were presented by William Gray, M.D., from Lankenau Heart Institute, Wynnewood, Penn., and Vivek Reddy, M.D., from Mount Sinai Hospital in New York. #TCT2020 #TCTconnect

News | Left Atrial Appendage (LAA) Occluders

Conformal Medical CLAAS LAA Occluder Shows Promising Clinical Results at TCT 2020

October 16, 2020 — Positive clinical data from first-in-human studies of the Conformal Medical left atrial appendage ...

October 16, 2020

The Abbott Vascular Xience Sierra drug eluting stent (DES). The XIENCE 28 and XIENCE 90 studies presented at TCT 2020 showed the stent can be used safely with only one month of dual antiplatelet therapy (DAPT). #TCT #TCTconnect #TCT2020

News | Stents Drug Eluting

Shorter DAPT With Xience Stent is Noninferior to Standard DAPT

October 16, 2020 – Results from the XIENCE 90/28 clinical trials have shown that a shorter course of dual-antiplatelet ...

October 16, 2020

The Keystone Heart TriGuard 3 (TG3) is a self-stabilizing cerebral embolic deflection filter used in patients undergoing transcatheter aortic valve replacement (TAVR). The device is designed to reduce TAVR complications of cerebral embolization and ischemic stroke. #TCT #TCT2020 #TCTconnect

News | Heart Valve Technology

Keystone Heart TAVR Embolic Protection Device Did Not Demonstrate Superiority

October 15, 2020 – The REFLECT II randomized clinical trial evaluating the safety and efficacy of the Keystone Heart ...

October 15, 2020

Philip's co-registration technology showing angiography overlaid with iFR in a coronary vessel segment with a system of dots that show regions where the hemodynamic pressure drops occur. This can aid in identifying culprit lesions. #TCT #TCT2020 #TCTconnect

News | FFR Technologies

DEFINE PCI Study One-year Data Show Potential of Treating Residual Ischemia to Improve Outcomes for Coronary Stenting

October 15, 2020 — The one-year results of the late-breaking DEFINE PCI study showed patients had improved outcomes and ...

October 15, 2020

The Boston Scientific Acurate neo self-expanding TAVR valve (left) did not perform as well clinically as the Medtronic CoreValve Evolut TAVR valve (right) in the SCOPE II trial presented at TCT 2020. #TCT #TCT2020 #TCTconnect

Feature | Heart Valve Technology

Acurate neo TAVR Valve Fails to Meet Noninferiority With Medtronic CoreValve Evolut

October 15, 2020 – The SCOPE II trial comparing the Boston Scientific Acurate neo vs. Medtronic CoreValve Evolut TAVR ...

October 15, 2020

An illustration showing the MitraClip catheter entering the left atrium through a transseptal puncture. #TCT2020 #TCTconnect

News | Heart Valve Technology

Transcatheter Closure of Residual ASD After Transcatheter Mitral Valve Repair Was Not Superior to Medical Therapy

October 15, 2020 – The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial ...

October 15, 2020

Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation.

News | TCT

ACC and CRF Create the Martin B. Leon Center for Cardiovascular Transformation

October 14, 2020 — The American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) are ...

October 14, 2020

News | Coronavirus (COVID-19)

COVID-19 Positive STEMI Patients Have Higher Mortality

October 14, 2020 – The first outcomes data from the North American COVID-19 ST-Segment Elevation Myocardial Infarction ...

October 14, 2020

Siemens Healthineers has introduced a new version of its c.cam dedicated SPECT cardiac nuclear medicine system to the U.S. market. This single-photon emission computed tomography (SPECT) scanner with a reclining patient chair offers nuclear cardiology providers a low total cost of ownership, ease of installation, and a high level of image quality.

News | Nuclear Imaging

Siemens Healthineers Debuts New Version of c.cam Cardiac SPECT System

September 30, 2020 — Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine ...

October 07, 2020

Chest X-ray of a congestive heart failure patient, showing fluid in the lower portions of the lungs and an enlarged heart. Getty Images

News | Heart Failure

ACC and Novartis Collaborate to Optimize Heart Failure Care With TRANSFORM Study

October 5, 2020 — The American College of Cardiology (ACC) says heart failure (HF) is a cardiovascular epidemic. In ...

October 05, 2020

News | VIVA

The Latest Vascular Interventional Clinical Data Presented at VIVA 2020

October 5, 2020 — The Vascular Interventional Advances (VIVA) virtual conference will feature 10 late-breaking clinical ...

October 05, 2020

Videos | Artificial Intelligence

VIDEO: Use of Artificial Intelligence in Nuclear Imaging

Ernest Garcia, Ph.D., MASNC, FAHA, endowed professor in cardiac imaging, director of nuclear cardiology R&D laboratory ...

September 25, 2020

TCT 2020 Late-breaking Study trial Presentations Announced. #TCTconnect #TCT2020 #TCT

Feature | TCT

TCT 2020 Late-breaking Study Presentations Announced

October 15, 2020 — The late-breaking studies are one of the hallmarks of the annual Transcatheter Cardiovascular ...

October 15, 2020